SCHEMBL6777388

SCHEMBL6777388

Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccncc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 19/20 1.00
KDR P35968 18/20 1.00
PDGFRB P09619 7/20 0.79
KIT P10721 6/20 0.79
CSF1R P07333 2/20 0.79
FLT4 P35916 2/20 0.79
CIT O14578 1/20 0.79
EGFR P00533 1/20 0.79
HLA-A P04439 1/20 0.79
RET P07949 1/20 0.79
PDGFRA P16234 1/20 0.79
RPS6KB1 P23443 1/20 0.79
FRK P42685 1/20 0.79
CDK8 P49336 1/20 0.79
DDR1 Q08345 1/20 0.79
STK3 Q13188 1/20 0.79
PTK6 Q13882 1/20 0.79
MAP3K19 Q56UN5 1/20 0.79
CDK19 Q9BWU1 1/20 0.79
MAP3K20 Q9NYL2 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608330 0.95 FLT1 (1.00) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL18286 0.88 FLT1 (1.00) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL29350047 0.88 FLT1 (1.00) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL905616 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL6131018 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL6131019 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL6131017 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL905598 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL29633763 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL28147347 0.87 FLT1 (0.97) FLT1KDRPDGFRBKITCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514974-B2 1-(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine for example NOVARTIS AG (CH) 2003-02-04 US claimed
US-6710047-B2 INHIBIT THE ACTIVITY OF THE VEGF RECEPTOR TYROSINE KINASE AND THE GROWTH OF TUMOURS NOVARTIS AG (CH) 2004-03-23 US disclosed
US-6514974-B2 1-(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine for example NOVARTIS AG (CH) 2003-02-04 US disclosed